Your browser doesn't support javascript.
loading
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.
Dieckmann, Klaus-Peter; Pokrivcak, Tomas; Geczi, Lajos; Niehaus, David; Dralle-Filiz, Inken; Matthies, Cord; Dienes, Tamas; Zschäbitz, Stefanie; Paffenholz, Pia; Gschliesser, Tanja; Pichler, Renate; Mego, Michal; Bader, Pia; Zengerling, Friedemann; Heinzelbecker, Julia; Krausewitz, Philipp; Krege, Susanne; Aurilio, Gaetano; Aksoy, Cem; Hentrich, Marcus; Seidel, Christoph; Törzsök, Péter; Nestler, Tim; Majewski, Matthaeus; Hiester, Andreas; Buchler, Tomas; Vallet, Sonia; Studentova, Hana; Schönburg, Sandra; Niedersüß-Beke, Dora; Ring, Julia; Trenti, Emanuela; Heidenreich, Axel; Wülfing, Christian; Isbarn, Hendrik; Pichlmeier, Uwe; Pichler, Martin.
Affiliation
  • Dieckmann KP; Department of Urology, Hodentumorzentrum, Asklepios Klinik Altona, Paul Ehrlich Straße 1, 22763 Hamburg, Germany.
  • Pokrivcak T; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Masaryk University, Brno, Czech Republic.
  • Geczi L; National Institute of Oncology, Budapest, Hungary.
  • Niehaus D; Department of Urology, Asklepios Klinik Altona, Hamburg, Germany.
  • Dralle-Filiz I; Department of Urology, Albertinen-Krankenhaus, Hamburg, Germany.
  • Matthies C; Department of Urology, Bundeswehrkrankenhaus Hamburg, Hamburg, Germany.
  • Dienes T; National Institute of Oncology, Budapest, Hungary.
  • Zschäbitz S; Department of Medical Oncology, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Paffenholz P; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University Hospital Cologne, Cologne, Germany.
  • Gschliesser T; Department of Urology, Klinikum Klagenfurt, Klagenfurt, Austria.
  • Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
  • Mego M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
  • Bader P; Department of Urology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Zengerling F; Department of Urology, Universitätsklinikum Ulm, Ulm, Germany.
  • Heinzelbecker J; Department of Urology and Pediatric Urology, University Medical Centre, Saarland University, Homburg/Saar, Germany.
  • Krausewitz P; Department of Urology and Pediatric Urology, Universitätsklinikum Bonn, Bonn, Germany.
  • Krege S; Department of Urology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
  • Aurilio G; Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Aksoy C; Klinik und Poliklinik für Urologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, Munich, Germany.
  • Seidel C; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Törzsök P; Department of Urology and Andrology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Nestler T; Department of Urology, Bundeswehrzentralkrankenhaus Koblenz, Koblenz, Germany.
  • Majewski M; Department of Urology, Bundeswehrkrankenhaus Ulm, Ulm, Germany.
  • Hiester A; Department of Urology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Buchler T; Department of Oncology, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Vallet S; Department of Internal Medicine II, Universitätsklinikum Krems, Krems, AustriaDepartment of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.
  • Studentova H; Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.
  • Schönburg S; Department of Urology, Universitätsklinikum Halle (Saale), Halle (Saale), Germany.
  • Niedersüß-Beke D; Department of Medical Oncology, Wilhelminenspital, Vienna, Austria.
  • Ring J; Department of Urology, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.
  • Trenti E; Department of Urology, Central Hospital Bolzano, Bolzano, Italy.
  • Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University Hospital Cologne, Cologne, Germany.
  • Wülfing C; Department of Urology, Asklepios Klinik Altona, Hamburg, Germany.
  • Isbarn H; Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pichlmeier U; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pichler M; Division of Oncology, Medical University of Graz, Graz, Austria.
Ther Adv Med Oncol ; 14: 17588359221086813, 2022.
Article in En | MEDLINE | ID: mdl-35386956
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Ther Adv Med Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Ther Adv Med Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: